Gen Shinozaki

Dr. Gen Shinozaki explores cutting-edge topics in Psychiatry and Behavioral Sciences as an Associate Professor at Stanford Medicine. With a specialization in Psychiatry, Psychosomatic Medicine, and Consultation Liaison Psychiatry, Dr. Shinozaki brings a wealth of knowledge and expertise to his field. He is board certified in both Psychosomatic Medicine/Consultation Liaison Psychiatry and Psychiatry by the American Board of Psychiatry and Neurology, underscoring his commitment to excellence in psychiatric care. As a Distinguished Fellow of the American Psychiatric Association and a Fellow of the Academy of Consultation Liaison Psychiatry, Dr. Shinozaki is recognized for his significant contributions to the field. His research is primarily focused on the epigenetic mechanisms underlying delirium pathophysiology, as well as the broader implications of neuroinflammation and aging. His work aims to unravel the complex interactions between these factors, providing insights that could lead to improved patient care and outcomes. Dr. Shinozaki's innovative research endeavors include the development of epigenetic biomarkers for delirium, which hold the potential to revolutionize the way this condition is diagnosed and managed. By identifying specific epigenetic changes associated with delirium, his team hopes to pave the way for more targeted and effective interventions. In addition to his work on biomarkers, Dr. Shinozaki is also involved in the creation of a small, point-of-care EEG device designed to detect delirium and predict patient outcomes. This device represents a significant advancement in the field, offering a portable and efficient means of assessing patients in various clinical settings. Through these efforts, Dr. Shinozaki and his team are at the forefront of developing novel tools and strategies to enhance the understanding and treatment of delirium. Dr. Shinozaki's dedication to advancing psychiatric research and improving patient care is evident in his ongoing projects and collaborations. His work not only contributes to the academic community but also has the potential to make a tangible impact on the lives of patients and their families. As he continues to explore the intersections of neuroinflammation, aging, and epigenetics, Dr. Shinozaki remains a leading figure in the quest to better understand and address the complexities of delirium and related conditions.